Check-Cap Ltd. (MBAI) Stock Price
MBAIStock
$8.08+78.27%52W
Market Cap$11.11M
P/E2.90x
PEG Ratio—
Div yield—
Beta0.72
MBAI Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-48.48%
Price vs S&P 500 (4W)6.34%
VGM Score42.77
P/E Ratio (Annual)2.90x
MBAI Earnings Surprise History
Q4 22-0.64est. -0.98
Q1 23-0.76est. -0.74
Q2 23-0.94est. -0.53
Q3 23-0.43est. -0.17
MBAI Analyst Recommendations
Apr 2024
May 2024
Jun 2024
Jul 2024
2.17
2.17
2.17
2.17
Industry Peers — X-Ray Equipment(5)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MBAICheck-Cap Ltd. | — | — | C | $8.08 |
| GEHCGE HealthCare Technologies Inc. Common Stock | B | D | C | $73.91 |
| PHGKONINKLIJKE PHILIPS N.V. | B | D | C | $27.43 |
| BFLYButterfly Network, Inc. | F | A | A | $9.04 |
| NNOXNANO-X IMAGING LTD Ordinary Shares | B | C | F | $0.86 |
| HOLXHologic Inc | C | D | C | $0.00 |
About Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage diagnostics company developing C-Scan, an ingestible capsule that uses low-dose X-rays to screen for colorectal cancer and polyps without patient preparation or data retrieval. The swallowed capsule naturally transits the gastrointestinal tract while imaging, eliminating the need for colonoscopy prep. Based in Israel, the company plans to commercialize the technology in the United States, Europe, and Japan.